Literature DB >> 7579573

Pathway and regulation of JHIII-Bisepoxide biosynthesis in adult Drosophila melanogaster corpus allatum.

P Moshitzky1, S W Applebaum.   

Abstract

Adult female Drosophila melanogaster corpus allatum (CA) synthesize JHB3 from endogenous and exogenous precursors in vitro. We present evidence supporting the thesis that biosynthesis proceeds from precursor FA via initial epoxidation and terminal methylation on the basis of the following: (1) Methyl farnesoate is not epoxidized to JHIII or JHB3; (2) Authentic JHIII is not epoxidized to JHB3; and (3) FABE is markedly metabolized to JHB3. Cerebral allatostatic factors act at some stage subsequent to FA and this precursor is not normally rate-limiting. Additionally, neural inhibition from the brain acts at some biosynthetic step prior to FA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579573     DOI: 10.1002/arch.940300211

Source DB:  PubMed          Journal:  Arch Insect Biochem Physiol        ISSN: 0739-4462            Impact factor:   1.698


  4 in total

1.  Suppressed production of methyl farnesoid hormones yields developmental defects and lethality in Drosophila larvae.

Authors:  Davy Jones; Grace Jones; Peter Teal; Courey Hammac; Lexa Messmer; Kara Osborne; Yasser Hadj Belgacem; Jean-Rene Martin
Journal:  Gen Comp Endocrinol       Date:  2009-07-10       Impact factor: 2.822

2.  Rethinking Sesquiterpenoids: A Widespread Hormone in Animals.

Authors:  Wai Lok So; Zhenpeng Kai; Zhe Qu; William G Bendena; Jerome H L Hui
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

3.  Characterization of Drosophila melanogaster cytochrome P450 genes.

Authors:  Henry Chung; Tamar Sztal; Shivani Pasricha; Mohan Sridhar; Philip Batterham; Phillip J Daborn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

Review 4.  Juvenile Hormone Studies in Drosophila melanogaster.

Authors:  Xiaoshuai Zhang; Sheng Li; Suning Liu
Journal:  Front Physiol       Date:  2022-02-10       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.